CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
Exchange
NYSE
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001100682

Price chart

Open-market purchases and sales by CRL insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 27, 20264:21 PM ETAug 25, 2026FOSTER JAMES CDirectorSSaleCommon Stock−33.56K$300.00−$10.07M31.6K−51.5%SEC10b5-1
Aug 20, 20264:33 PM ETAug 19, 2026Parisotto Shannon MCEVP, Disc & Safety AssessmentSSaleCommon Stock−2.04K$294.12−$599.71K4.81K−29.8%SEC10b5-1
Aug 20, 20264:31 PM ETAug 18, 2026Andrews Nancy CDirectorSSaleCommon Stock−573$285.24−$163.44K1.44K−28.5%SEC
Aug 13, 20264:37 PM ETAug 11, 2026Girshick BirgitChief Executive OfficerSSaleCommon Stock−6.5K$279.90−$1.82M36.01K−15.3%SEC10b5-1
Aug 13, 20264:34 PM ETAug 11, 2026Parisotto Shannon MCEVP, Disc & Safety AssessmentSSaleCommon Stock−3.71K$279.66−$1.04M4.81K−43.6%SEC10b5-1

The largest institutional positions in CRL at the end of Q2 2026.

Institutions holding CRL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC4,239,752$961.53M0.04%+783,508+22.7%Added
BlackRock, Inc.3,798,560$861.48M0.01%−60,540−1.6%Reduced
VANGUARD CAPITAL MANAGEMENT LLC3,149,288$714.23M0.02%−52,916−1.7%Reduced
Invesco Ltd.2,984,785$676.92M0.05%+587,533+24.5%Added
HARRIS ASSOCIATES L PSuperinvestorHarris Associates (Oakmark)2,241,144$508.27M0.68%+87,848+4.1%Added